z-logo
Premium
Platelet‐activating factor induces matrix metalloproteinase‐9 expression through Ca 2+ ‐ or PI3K‐dependent signaling pathway in a human vascular endothelial cell line
Author(s) -
Ko Hyun-Mi,
Kang Jee-Hae,
Choi Jung-Hwa,
Park Sung Jun,
Bai Suk,
Im Suhn-Young
Publication year - 2005
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2005.10.027
Subject(s) - signal transduction , mapk/erk pathway , pi3k/akt/mtor pathway , microbiology and biotechnology , phosphatidylinositol , angiogenesis , chemistry , kinase , platelet activating factor , biology , cancer research , endocrinology
Platelet‐activating factor (PAF) augments angiogenesis by promoting the synthesis of a variety of angiogenic factors, via the nuclear factor (NF)‐κB activation. Recently, we reported that PAF upregulates MMP‐9 expression in a NF‐κB‐dependent manner. In this study, we investigated the signaling pathway involved in PAF‐induced MMP‐9 expression in ECV304 cells. Our current data indicate that the Ca 2+ ‐ or phosphatidylinositol 3‐kinase (PI3K)‐dependent signaling pathway is necessary for PAF‐induced MMP‐9 expression. Furthermore, PAF‐induced NF‐κB activation was blocked by selective inhibitors of Ca 2+ , PI3K, or extracellular signal‐regulated kinase (ERK). Our results suggest that PAF‐induced MMP‐9 expression, in a NF‐κB‐dependent manner, is regulated by Ca 2+ , PI3K and ERK signaling pathways.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom